Top 5 News From ChinaKnowledge.comBeijing Capital Int'l Airport's net profit jumps 85.6% in H1Fuyao Glass Industry to issue RMB 800 mln in financing billsToshiba loses share in China TV marketJapan's Isetan to grow presence in ChinaChina's FDI down 35.7% in Jul Aug. 18, 2009 (China Knowledge) - North China Pharmaceutical Group Corp, parent firm of North China Pharmaceutical Co Ltd<600812>, said on Sunday that the firm plans to achieve RMB 10 billion of sales revenue in 2011.
The RMB 10-million sales target is the first goal of NCPC's three-phase development plan, and it is expected that its sales revenue will amount to RMB 20 billion and RMB 30 billion in 2013 and 2015 respectively, according to Wang Sheping, chairman of NCPC.
Wang, who is also chairman of Jizhong Energy Group, started restructuring the troubled pharmaceutical group from June after the appointment.
Jizhong Energy received the 100% equity interest of state-owned NCPC in July, and will inject capital into NCPC gradually to revive the latter company, according to sources.